{"id":595407,"date":"2025-12-02T08:43:56","date_gmt":"2025-12-02T14:43:56","guid":{"rendered":"https:\/\/cerebrodigital.net\/?p=595407"},"modified":"2026-02-02T16:45:23","modified_gmt":"2026-02-02T22:45:23","slug":"seventh-recorded-case-hiv-remission","status":"publish","type":"post","link":"https:\/\/cerebrodigital.net\/en\/seventh-recorded-case-hiv-remission\/","title":{"rendered":"Seventh recorded case of HIV remission after stem cell transplant brings new hope"},"content":{"rendered":"\n

A 60-year-old man in Germany has become the seventh known person to achieve prolonged HIV remission after receiving a stem cell transplant. The finding rekindles hope for broader treatments, given that the donor did not carry the usual complete protective mutation.<\/p>\n\n\n\n

What makes this transplant special, and why it matters<\/strong><\/h2>\n\n\n\n
\"S\u00e9ptimo<\/figure>\n\n\n\n

The new case was presented at the AIDS 2024 conference in Munich and confirmed by researchers as a remarkable finding. The patient\u2014diagnosed with HIV in 2009 and with acute myeloid leukemia in 2015\u2014received a transplant <\/a>that same year. His donor carried only one copy of the CCR5 \u039432 mutation, unlike previous cases with two copies.<\/p>\n\n\n\n

Until now, cases of HIV \u201ccure\u201d after transplant had relied on donors with both copies of the CCR5 \u039432 mutation, which makes their cells resistant to the virus. This new result suggests that even a heterozygous donor may be sufficient to achieve sustained remission, drastically expanding the potential donor pool.<\/p>\n\n\n\n

After the transplant, the patient stopped antiretroviral medication in 2018. Six years later, no trace of HIV can be detected in his blood or in intestinal tissue biopsies, indicating sustained remission<\/strong>.<\/p>\n\n\n\n

This case, dubbed \u201cthe next Berlin patient,\u201d does not immediately change treatment options for most people living with HIV\u2014the transplant remains dangerous, costly, and reserved for those who require it due to cancer\u2014but it does represent a key proof of concept<\/strong>: a cure could be more accessible if replicated with heterozygous donors.<\/p>\n\n\n\n

Limitations and caution: why this is not yet a generalizable cure<\/strong><\/h2>\n\n\n\n
\"S\u00e9ptimo<\/figure>\n\n\n\n

Despite the success, experts warn that this type of transplant cannot be applied as a general HIV treatment. The procedure involves intensive chemotherapy, risks of rejection, complications, and even mortality<\/strong>, so it is only justified in patients with severe hematological diseases.<\/p>\n\n\n\n

Moreover, the exact mechanism of viral eradication is not fully understood. It remains unclear why a donor with only one copy of CCR5 \u039432 achieved such lasting results. Hypotheses include: the complete replacement of the immune system, the elimination of residual infected cells, and a possible immune action from the graft.<\/p>\n\n\n\n

For this reason, although the case broadens the horizon, researchers agree that it cannot yet be considered a universa<\/strong>l cure. Other less invasive strategies\u2014such as gene therapies or immunotherapies\u2014are still necessary for most people living with HIV to benefit without extreme risks.<\/p>\n\n\n\n

What this breakthrough represents for the future of HIV therapies<\/strong><\/h2>\n\n\n\n

The success of the seventh case renews hope for a lasting HIV cure<\/strong>, beyond the continued use of antiretroviral drugs. It expands the possibility of having more suitable donors<\/strong>, since many more carry only one copy of the CCR5 \u039432 mutation.<\/p>\n\n\n\n

Researchers can now focus efforts on less aggressive techniques<\/strong>: gene editing, immunotherapies, or cell therapies that mimic the effect of the transplant without the need for chemotherapy or risk of rejection.<\/p>\n\n\n\n

In addition, this case demonstrates that prolonged remission is possible without completely eliminating the CCR5 receptor\u2014suggesting that other immunological factors may be key. This opening could accelerate the development of treatments accessible on a global scale.<\/p>\n\n\n\n

For now, this milestone brings hope to millions of people living with HIV: it shows that, although rare, a real cure is possible.<\/p>\n\n\n\n

The seventh successful case of HIV remission after stem cell transplant broadens the therapeutic horizon. Although not an option for everyone, it demonstrates that long-term viral elimination is possible and paves the way toward safer, more accessible treatments, bringing closer a future with a reduced HIV burden worldwide.<\/em><\/strong><\/p>\n\n\n\n

Reference:<\/p>\n\n\n\n